Mivebresib
€ Preis anfragen
Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM[1].
- CAS number: 1445993-26-9
- Purity: 99.69
- Formula: C22H19F2N3O4S
- Solubility: DMSO : 100 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic
- warming
- heat to 60°C)
- SMILES: CCS(=O)(NC1=CC=C(OC2=CC=C(F)C=C2F)C(C3=CN(C)C(C4=C3C=CN4)=O)=C1)=O
- Molecular Weight: 459.47
- Applications: Cancer-programmed cell death
- -20°C, 3 years
- 4°C, 2 years (Powder)
